Cargando...
Hormone Therapy and Young-Onset Breast Cancer
Estrogen plus progestin hormone therapy (HT) is associated with an increased risk of postmenopausal breast cancer, but few studies have examined the impact of HT use on the risk of breast cancer in younger women. We assessed the association between estrogen plus progestin HT or unopposed estrogen HT...
Guardado en:
| Publicado en: | Am J Epidemiol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4423525/ https://ncbi.nlm.nih.gov/pubmed/25698646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwu347 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|